Effect of resveratrol and Regrapex-R-forte on Trichosporon cutaneum biofilm
- 96 Downloads
Microorganisms that cause chronic infections exist predominantly as surface-attached stable communities known as biofilms. Microbial cells in biofilms are highly resistant to conventional antibiotics and other forms of antimicrobial treatment; therefore, modern medicine tries to develop new drugs that exhibit anti-biofilm activity. We investigated the influence of a plant polyphenolic compound resveratrol (representative of the stilbene family) on the opportunistic pathogen Trichosporon cutaneum. Besides the influence on the planktonic cells of T. cutaneum, the ability to inhibit biofilm formation and to eradicate mature biofilm was studied. We have tested resveratrol as pure compound, as well as resveratrol in complex plant extract—the commercially available dietary supplement Regrapex-R-forte, which contains the extract of Vitis vinifera grape and extract of Polygonum cuspidatum root. Regrapex-R-forte is rich in stilbenes and other biologically active substances. Light microscopy imaging, confocal microscopy, and crystal violet staining were used to quantify and visualize the biofilm. The metabolic activity of biofilm-forming cells was studied by the tetrazolium salt assay. Amphotericin B had higher activity against planktonic cells; however, resveratrol and Regrapex-R-forte showed anti-biofilm effects, both in inhibition of biofilm formation and in the eradication of mature biofilm. The minimum biofilm eradicating concentration (MBEC80) for Regrapex-R-forte was found to be 2222 mg/L (in which resveratrol concentration is 200 mg/L). These methods demonstrated that Regrapex-R-forte can be employed as an anti-biofilm agent, as it has similar effect as amphotericin B (MBEC80 = 700 mg/L), which is routinely used in clinical practice.
KeywordsAnti-biofilm activity Trichosporon Stilbene Plant extract
This work was supported by the Czech Science Foundation (GACR) [17-15936S] and by the “Operational Programme Prague – Competitiveness” (CZ.2.16/3.1.00/24503) and the “National Program of Sustainability I” - NPU I (LO1601 - No.: MSMT-43760/2015).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- Herrera CL, Alvear M, Barrientos L, Montenegro G, Salazar LA (2010) The antifungal effect of six commercial extracts of Chilean propolis on Candida spp. Cienc Invest Agrar 37(1):75–84Google Scholar
- Houille B, Papon N, Boudesocque L, Bourdeaud E, Besseau S, Courdavault V, Enguehard-Gueiffier C, Delanoue G, Guerin L, Bouchara JP, Clastre M, Giglioli-Guivarch N, Guillard J, Lanoue A (2014) Antifungal activity of resveratrol derivatives against Candida species. J Nat Prod 77(7):1658–1662CrossRefGoogle Scholar
- Jun JH, Seu YB, Lee DG (2007) Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C. albicans. J Microbiol Biotechnol 17(8):1324–1329Google Scholar
- López-Nicolás JM, Núñez-Delicado E, Pérez-López AJ, Barrachina ÁC, Cuadra-Crespo P (2006) Determination of stoichiometric coefficients and apparent formation constants for β-cyclodextrin complexes of trans-resveratrol using reversed-phase liquid chromatography. J Chromatogr A 1135(2):158–165CrossRefGoogle Scholar
- Mesa-Arango AC, Scorzoni L, Zaragoza O (2012) It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug. Front Microbiol 3(286). https://doi.org/10.3389/fmicb.2012.00286